Document is current

Article History

Received: 30 October 2024

Accepted: 7 January 2025

First Online: 11 January 2025

Declarations

:

: This study was approved by the Ethics Committee of the Japan Institute for Advancement of Medical Education Program (JAMEP; No. 22–30) and conducted in accordance with the principles of the Declaration of Helsinki. All participants reviewed the study document detailing data anonymisation, voluntary participation, and the dissemination of research results prior to participation. Only participants who provided informed consent (opt-in) were included in the study. Additionally, the participants could withdraw at any time. Clinical trial number: not applicable.

: Informed consent was obtained from all participants for the publication of identifying information in an online open-access publication.

: Dr. Nishizaki received an honorarium from JAMEP as GM-ITE project manager. Dr. Tokuda is the JAMEP director. Dr. Tokuda and Dr. Shikino received an honorarium from JAMEP as speakers of the JAMEP lecture. Dr. Shimizu, Dr. Yamamoto, and Dr. Shikino received an honorarium from JAMEP as exam preparers of GM-ITE. This research was presented orally at the 56th Annual Meeting of the Japan Society for Medical Education on 10 August 2024. The other authors have no competing interests to declare.